Evaluation of growth hormone stimulation tests in cured acromegalic patients

Growth Hormone and IGF Research

Volumn 13, Issue 6, 2003, Pages 347-352

  Conceição, Flavia Lucia ^a,b   Fisker, Sanne ^a   Andersen, Marianne ^c   Kaal, Andreas ^a   Lunde Jørgensen, Jens Otto ^a   Vaisman, Mario ^b   Christiansen, Jens Sandahl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acromegaly; GHRH plus arginine test; Growth hormone deficiency; Insulin tolerance test

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; NEUTRAL INSULIN; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; INSULIN TOLERANCE TEST; MALE; PRIORITY JOURNAL; PROVOCATION TEST; STATISTICAL SIGNIFICANCE;

EID: 0345169982     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00124-2     Document Type: Article

References (31)

1. J.O. Jorgensen, S.A. Pedersen, L. Thuesen, J. Jorgensen, T. Ingemann-Hansen, N.E. Skakkebaek, et al., Beneficial effects of growth hormone treatment in GH-deficient adults, Lancet 1 (8649) (1989) 1221-1225.
2. F. Salomon, R.C. Cuneo, R. Hesp, P.H. Sonksen, The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency, N. Engl. J. Med. 321 (26) (1989) 1797-1803.
3. H. de Boer, F. Roelfsema, M. Frolich, H.A. Kamphuisen, A.P. van Seters, Plasma growth hormone profiles and sleep: a study of 13 treated acromegalics, Clin. Endocrinol. (Oxf.) 30 (3) (1989) 251-261.
4. U. Feldt-Rasmussen, R. Abs, B.A. Bengtsson, H. Bennmarker, M. Bramnert, E. Hernberg-Stahl, et al., Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease, Eur. J. Endocrinol. 146 (1) (2002) 67-74.
5. R.D. Murray, S.R. Peacey, A. Rahim, A.A. Toogood, M.O. Thorner, S.M. Shalet, The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients, Clin. Endocrinol. (Oxf.) 54 (1) (2001) 37-44.
6. A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, et al., Criteria for cure of acromegaly: a consensus statement, J. Clin. Endocrinol. Metab. 85 (2) (2000) 526-529.
7. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab. 83 (2) (1998) 379-381.
8. G. Aimaretti, C. Baffoni, L. DiVito, S. Bellone, S. Grottoli, M. Maccario, et al., Comparisons among old and new provocative tests of GH secretion in 178 normal adults, Eur. J. Endocrinol. 142 (4) (2000) 347-352.
9. E. Ghigo, G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, F. Camanni, New approach to the diagnosis of growth hormone deficiency in adults, Eur. J. Endocrinol. 134 (3) (1996) 352-356.
10. J. Frystyk, B. Dinesen, H. Orskov, Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II, Growth Regul. 5 (4) (1995) 169-176.
11. S. Fisker, J. Frystyk, L. Skriver, E. Vestbo, K.K. Ho, H. Orskov, A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum, Eur. J. Clin. Invest. 26 (9) (1996) 779-785.
12. G. Aimaretti, G. Corneli, P. Razzore, S. Bellone, C. Baffoni, E. Arvat, et al., Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults, J. Clin. Endocrinol. Metab. 83 (5) (1998) 1615-1618.
13. B.M. Biller, M.H. Samuels, A. Zagar, D.M. Cook, B.M. Arafah, V. Bonert, et al., Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency, J. Clin. Endocrinol. Metab. 87 (2) (2002) 2067-2079.
14. M. Semer, A.C. Faria, M. Nery, L.R. Salgado, M. Knoepfelmacher, B.L. Wajchenberg, et al., Growth hormone pulsatility in active and cured acromegalic subjects, J. Clin. Endocrinol. Metab. 80 (12) (1995) 3767-3770.
15. B.G. van den, M. Frolich, J.D. Veldhuis, F. Roelfsema, Growth hormone secretion in recently operated acromegalic patients, J. Clin. Endocrinol. Metab. 79 (6) (1994) 1706-1715.
16. S. Fisker, J.O. Jorgensen, N. Vahl, H. Orskov, J.S. Christiansen, Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults, Eur. J. Endocrinol. 141 (6) (1999) 601-608.
17. J.O. Jorgensen, N. Vahl, T.B. Hansen, C. Skjaerbaek, S. Fisker, H. Orskov, et al., Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects, Clin. Endocrinol. (Oxf.) 48 (4) (1998) 479-486.
18. S. Fisker, N. Vahl, T.B. Hansen, J.O. Jorgensen, C. Hagen, H. Orskov, et al., Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial, Growth Horm. IGF Res. 8 (2) (1998) 105-112.
19. T. Amit, M.B. Youdim, Z. Hochberg, Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function?, J. Clin. Endocrinol. Metab. 85 (3) (2000) 927-932.
20. T. Amit, S. Ish-Shalom, B. Glaser, M.B. Youdim, Z. Hochberg, Growth-hormone-binding protein in patients with acromegaly, Horm. Res. 37 (6) (1992) 205-211.
21. A. Iranmanesh, G. Lizarralde, J.D. Veldhuis, Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men, J. Clin. Endocrinol. Metab. 73 (5) (1991) 1081-1088.
22. M.H. Rasmussen, A. Hvidberg, A. Juul, K.M. Main, A. Gotfredsen, N.E. Skakkebaek, et al., Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects, J. Clin. Endocrinol. Metab. 80 (4) (1995) 1407-1415, Erratum in: J. Clin. Endocrinol. Metab. 80 (8) (1995) Aug, 2446.
23. T. Williams, M. Berelowitz, S.N. Joffe, M.O. Thorner, J. Rivier, W. Vale, et al., Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction, N. Engl. J. Med. 311 (22) (1984) 1403-1407.
24. N. Vahl, J.O. Jorgensen, A.G. Jurik, J.S. Christiansen, Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults, J. Clin. Endocrinol. Metab. 81 (6) (1996) 2209-2215.
25. T. Imaki, T. Shibasaki, K. Shizume, A. Masuda, M. Hotta, Y. Kiyosawa, et al., The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man, J. Clin. Endocrinol. Metab. 60 (2) (1985) 290-293.
26. E.J. Lee, S.Y. Nam, K.R. Kim, H.C. Lee, J.H. Cho, M.S. Nam, et al., Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects, J. Clin. Endocrinol. Metab. 80 (8) (1995) 2495-2498.
27. F. Cordido, R. Peino, A. Penalva, C.V. Alvarez, F.F. Casanueva, C. Dieguez, Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression, J. Clin. Endocrinol. Metab. 81 (3) (1996) 914-918.
28. M.L. Hartman, B.J. Crowe, B.M. Biller, K.K. Ho, D.R. Clemmons, J.J. Chipmann, et al., Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?, J. Clin. Endocrinol. Metab. 87 (2) (2002) 477-485.
29. A.A. Toogood, C.G. Beardwell, S.M. Shalet, The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism, Clin. Endocrinol. (Oxf.) 41 (4) (1994) 511-516.
30. S.E. Hankinson, W.C. Willett, G.A. Colditz, D.J. Hunter, D.S. Michaud, B. Deroo, et al., Circulating concentrations of insulin-like growth factor-I and risk of breast cancer, Lancet 351 (9113) (1998) 1393-1396.
31. J.M. Chan, M.J. Stampfer, E. Giovannucci, P.H. Gann, J. Ma, P. Wilkinson, et al., Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study, Science 279 (5350) (1998) 563-566.